Lastly, Cox multivariate analysis showed that MYCN immune score is an independent prognostic factor and significantly associated at overall and event free survival in both NB cohorts and also in non-MNA patients (Figures S14A–H). This evidence concerns the gene MYCN and neuroblastoma.